NCT06261489: Cannabis (THC vs. CBD) in Multiple Sclerosis
- State
- Under way
- Phase
- Phase 2
- People
- 30 planned
- Started
- 5 Dec 2025
- Primary completion
- 30 Sep 2027
- Arms
- Tetrahydrocannabinol (THC) 25 mg
- Results
- None posted
- 15 Feb 2024: Trial registered
- 5 Dec 2025: Trial started